DE60207273D1 - Aminopyrrol verbindungen als entzündungshemmende wirkstoffe - Google Patents

Aminopyrrol verbindungen als entzündungshemmende wirkstoffe

Info

Publication number
DE60207273D1
DE60207273D1 DE60207273T DE60207273T DE60207273D1 DE 60207273 D1 DE60207273 D1 DE 60207273D1 DE 60207273 T DE60207273 T DE 60207273T DE 60207273 T DE60207273 T DE 60207273T DE 60207273 D1 DE60207273 D1 DE 60207273D1
Authority
DE
Germany
Prior art keywords
aminopyrrol
compounds
active substances
inflammatory active
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60207273T
Other languages
English (en)
Other versions
DE60207273T2 (de
Inventor
Michael Goldstein
Mark Rotstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE60207273D1 publication Critical patent/DE60207273D1/de
Application granted granted Critical
Publication of DE60207273T2 publication Critical patent/DE60207273T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60207273T 2001-08-30 2002-08-26 Aminopyrrolverbindungen als entzündungshemmende Wirkstoffe Expired - Fee Related DE60207273T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31616901P 2001-08-30 2001-08-30
US316169P 2001-08-30
PCT/EP2002/009505 WO2003020715A1 (en) 2001-08-30 2002-08-26 Aminopyrrole compounds as antiinflammatory agents

Publications (2)

Publication Number Publication Date
DE60207273D1 true DE60207273D1 (de) 2005-12-15
DE60207273T2 DE60207273T2 (de) 2006-07-20

Family

ID=23227809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60207273T Expired - Fee Related DE60207273T2 (de) 2001-08-30 2002-08-26 Aminopyrrolverbindungen als entzündungshemmende Wirkstoffe

Country Status (16)

Country Link
US (1) US6696471B2 (de)
EP (1) EP1423378B1 (de)
JP (1) JP2005506324A (de)
KR (1) KR20040029075A (de)
CN (1) CN1281603C (de)
AR (1) AR037140A1 (de)
AT (1) ATE309239T1 (de)
AU (1) AU2002331179B2 (de)
BR (1) BR0212077A (de)
CA (1) CA2458808A1 (de)
DE (1) DE60207273T2 (de)
ES (1) ES2252509T3 (de)
MX (1) MXPA04001810A (de)
PL (1) PL373115A1 (de)
RU (1) RU2315045C2 (de)
WO (1) WO2003020715A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
WO2006020365A2 (en) * 2004-07-26 2006-02-23 The Regents Of The University Of California Method for prevention or treatment of inflamatory disease
US20100104536A1 (en) * 2007-03-20 2010-04-29 Indravadan Ambalal Modi P38 inhibitors
US20180325947A1 (en) 2015-10-27 2018-11-15 Children's Hospital Medical Center Use of mapk inhibitors to reduce loss of hematopoietic stem cells during ex vivo culture and/or genetic manipulation
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
AU2018346709A1 (en) 2017-10-05 2020-04-16 Fulcrum Therapeutics, Inc. Use of p38 inhibitors to reduce expression of DUX4
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9710352A (pt) 1996-07-11 1999-08-17 Pfizer Compostos piridilpirrole
WO1998007425A1 (en) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
PL344004A1 (en) 1998-05-05 2001-09-10 Hoffmann La Roche Pyrazole derivatives as p-38 map kinase inhibitors
AU3859999A (en) * 1998-05-14 1999-11-29 G.D. Searle & Co. 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors

Also Published As

Publication number Publication date
EP1423378A1 (de) 2004-06-02
US6696471B2 (en) 2004-02-24
AU2002331179B2 (en) 2008-04-17
PL373115A1 (en) 2005-08-08
RU2315045C2 (ru) 2008-01-20
RU2004109817A (ru) 2005-10-20
ES2252509T3 (es) 2006-05-16
WO2003020715A1 (en) 2003-03-13
CA2458808A1 (en) 2003-03-13
DE60207273T2 (de) 2006-07-20
CN1547578A (zh) 2004-11-17
US20030130319A1 (en) 2003-07-10
KR20040029075A (ko) 2004-04-03
ATE309239T1 (de) 2005-11-15
JP2005506324A (ja) 2005-03-03
BR0212077A (pt) 2004-09-28
CN1281603C (zh) 2006-10-25
AR037140A1 (es) 2004-10-27
MXPA04001810A (es) 2004-07-08
EP1423378B1 (de) 2005-11-09

Similar Documents

Publication Publication Date Title
ATE549328T1 (de) Aromatisch-heterocyclische verbindungen als entzündungshemmende mittel
DE60118917D1 (de) PYRROLOi2,3-DöPYRIMIDIN VERBINDUNGEN ALS IMMUNOSUPPRESSIVE WIRKSTOFFE
ATE299875T1 (de) Benzoamid-piperidin verbindungen als substanz p- antagonisten
ATE447565T1 (de) Spiro-hydantoin-verbindungen, die sich als entzündungshemmende mittel eignen
NO20014412L (no) Forbindelser nyttige som anti-inflammatoriske midler
ATE397926T1 (de) Glukokinase beeinflussende verbindungen
ATE259798T1 (de) Pharmazeutisch aktive verbindungen
NO20026253L (no) Organiske forbindelser
ATE309997T1 (de) Entzündungshemmende benzimidazolverbindungen
ATE473215T1 (de) 4-anilinchinazolinderivate als antiproliferative wirkstoffe
ITMI992711A0 (it) Composti organici
NO20021637L (no) Kjemikalske forbindelser
DE60129746D1 (de) Hetorocyclindazole und -azaindazole verbindungen als 5-hydroxytryptamine-6 liganden
AR028605A1 (es) Compuesto quimico
ATE278669T1 (de) Chemische verbindungen
MXPA03001425A (es) Compuestos farmaceuticos.
DE60210784D1 (de) Orale antidiabetische wirkstoffe
NO20014926D0 (no) Farmasöytiske forbindelser
DE60207273D1 (de) Aminopyrrol verbindungen als entzündungshemmende wirkstoffe
ATE380177T1 (de) Kalzilytische verbindungen
DE60201463D1 (de) Indanon-Derivate als Duftstoffe
DE60137755D1 (de) Calcilytische verbindungen
ATE405574T1 (de) Aryl-annellierte azapolyzyklische verbindungen
SE9901967D0 (sv) New solid dosage formulation
SE0000645D0 (sv) New pharmaceutically active compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee